Study: Surveillance is safe for small renal masses
A large retrospective study of older patients diagnosed with small kidney tumors showed that patients who undergo surgery to remove these tumors have the same risk of dying of kidney cancer over a 5-year period as those who undergo surveillance.
A large retrospective study of older patients diagnosed with small kidney tumors showed that patients who undergo surgery to remove these tumors have the same risk of dying of kidney cancer over a 5-year period as those who undergo surveillance.
Additionally, elderly patients treated with surgery for these small masses may be at greater risk for suffering a cardiovascular event and an earlier death from any cause. The findings, which were presented at the Genitourinary Cancers Symposium in Orlando, FL, suggest that surveillance with imaging, such as magnetic resonance imaging, ultrasound, and computed tomography, is a safe option for the management of small renal masses in the elderly.
"Our analysis indicates that physicians can comfortably tell an elderly patient, especially a patient that is not healthy enough to tolerate general anesthesia and surgery, that the likelihood of dying of kidney cancer is low and that kidney surgery is unlikely to extend their lives," said lead author William C. Huang, MD, of New York University Medical Center in New York. "However, since it is difficult to identify which tumors will become lethal, elderly patients who are completely healthy and have an extended life expectancy may opt for surgery."
In the study, the authors analyzed Surveillance, Epidemiology, and End Results registry data linked to Medicare claims for patients aged 66 years or older who were diagnosed with small renal masses. Out of 8,317 patients, 5,706 (70%) underwent surgery and 2,611 (31%) underwent surveillance. During a median follow-up of 4.8 years, 2,078 patients (25%) died overall, 277 (3%) of kidney cancer. The rates of kidney cancer-related death were the same among patients who received surgery and those who underwent surveillance.
Surveillance was also associated with a markedly lower risk of death from any cause as well as a lower risk of having a cardiovascular event, such as chronic heart failure, ischemic stroke, and vascular disease.
The authors also found that during the years 2000-‘07, the percentage of patients managed with surveillance increased from 25% to 37%.
Related Content
Mitochondrial metabolism may promote kidney cancer metastasis, new data show
August 14th 2024“The challenge now is to understand how these key aspects of mitochondrial metabolism become activated, why they stimulate metastasis, and whether we can safely block them,” says Ralph J. DeBerardinis, MD, PhD.
Dr. Richard Matulewicz discusses smoking cessation counseling and treatment among urologists
March 31st 2021“Because so many disease processes that we deal with are related to tobacco use and smoking specifically… I think this is absolutely our domain,” says Richard S. Matulewicz, MD, of tobacco cessation counseling and treatment.
Adding nivolumab to low-dose tivozanib does not improve PFS in renal cell carcinoma
July 19th 2024"While the addition of an ICI to low dose FOTIVDA did not improve PFS outcomes after prior ICI, we consider the control arm data an important, evidence-based and clinically meaningful contribution to the oncology community treating relapsed or refractory advanced RCC following front-line ICI combinations," says Michael P. Bailey.
